Mark Crockett, MDMolecular ImagingTargeted radiopharmaceuticals offer new hope for longer 'healthspans'Precision radiopharmaceuticals accurately target tumors while minimizing damage to healthy tissue, presenting an opportunity to extend not just lifespans but “healthspans,” Mark Crockett, MD, explains in this article.March 15, 2024Page 1 of 1Top StoriesCTUse thin slices on CT for preop periampullary adenocarcinoma imagingPreoperative CT in patients with periampullary adenocarcinoma should include thin slices to reduce the chance of a terminated Whipple procedure.Practice ManagementPrivate equity acquisition rising in radiologyPractice ManagementMICI Q2: Confidence in growth of imaging as profit center remains highNuclear MedicineAc-225: From nuclear waste to cancer treatmentSponsor ContentRegister for a FREE Webinar March 19 @ 10 a.m. PT / 1 p.m. ET
